Allelic loss on chromosome 9q is a very frequent event in bladder carcinogenesis. In recent years, efforts have been directed towards identifying the postulated tumour suppressor genes on this chromosome arm by deletion mapping and mutation analysis. However, no convincing candidate genes have been identified. This paper describes the development of chromosome 9q alterations in multiple recurrent superficial bladder cancers of ten patients and shows that loss of heterozygosity (LOH) on this chromosome is almost never the characteristic first step. The regions of loss are multiple and variable in different tumours from the same patient and expand in subsequent tumours. Moreover, the regions of loss vary from patient to patient. It is concluded that even if 9q harbours a bladder cancer gatekeeper gene, it is unlikely that the gene will be identified through LOH analysis alone.

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1215DOI Listing

Publication Analysis

Top Keywords

loh chromosome
8
superficial bladder
8
bladder cancers
8
regions loss
8
chromosome
5
random development
4
development loh
4
chromosome superficial
4
bladder
4
cancers allelic
4

Similar Publications

Chromosomal instability (CIN) is common in solid tumours and fuels evolutionary adaptation and poor prognosis by increasing intratumour heterogeneity. Systematic characterization of driver events in the TRACERx non-small-cell lung cancer (NSCLC) cohort identified that genetic alterations in six genes, including FAT1, result in homologous recombination (HR) repair deficiencies and CIN. Using orthogonal genetic and experimental approaches, we demonstrate that FAT1 alterations are positively selected before genome doubling and associated with HR deficiency.

View Article and Find Full Text PDF
Article Synopsis
  • * This study analyzed data from The Cancer Genome Atlas to investigate the effects of HOOK3 gene amplification on gene expression and patient survival in BUC, finding that HOOK3 amplification is associated with distinct gene changes and potential tumor suppression mechanisms.
  • * The results suggest that HOOK3 amplification may improve survival rates in BUC patients, indicating a protective role; however, more research is necessary to fully understand its mechanisms and therapeutic potential.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied genetic variations in primary CNS lymphoma (PCNSL) to find markers that could predict patient outcomes and responses to treatment.
  • They analyzed samples from 78 patients, finding that specific genetic changes, particularly on chromosome 6p and mutations in certain tumor suppressor genes, were linked to a high rate of disease progression and mortality.
  • The findings suggest that identifying these genetic markers can help doctors assess patient risk and customize therapies, leading to better treatment strategies in PCNSL.
View Article and Find Full Text PDF

Can developmental signals shatter or mend our genomes?

Trends Genet

December 2024

Department of Developmental Biology, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address:

Consensus holds that most cells in the embryo are genetically identical and have healthy genomes. However, embryonic cells with abnormal chromosomes are surprisingly frequent. In a recent publication, de Jaime-Soguero et al.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!